Shennon Biotechnologies: Funding, Investors & Team (Oct 2026)
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells, focusing on each cell individually, in order to create superior remedies for human diseases. It also assesses the operations of millions of immune cells to determine the most suitable objectives for cancer immunotherapy.
Shennon Biotechnologies has raised $25.0M across 2 funding rounds on record, the most recent an undisclosed round of $12.0M announced in Sep 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Shennon Biotechnologies Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Shennon Biotechnologies Funding Rounds
Shennon Biotechnologies raised $13.0M in a Seed announced in Mar 2023.
3.5 years later, an undisclosed round of $12.0M was announced in Sep 2026.
Shennon Biotechnologies Investors
9 investors are recorded in total; the 5 named above are those the record identifies.
Shennon Biotechnologies Founders and Leadership Team
Contact details for the Shennon Biotechnologies team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Shennon Biotechnologies Funding Compared to Other Biotechnology Startups
Shennon Biotechnologies' latest round of $12.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Shennon Biotechnologies in Biotechnology and San Francisco
Companies Similar to Shennon Biotechnologies
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Shennon Biotechnologies Funding FAQs
What does Shennon Biotechnologies do?
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells, focusing on each cell individually, in order to create superior remedies for human diseases. It also assesses the operations of millions of immune cells to determine the most suitable objectives for cancer immunotherapy.
How much funding has Shennon Biotechnologies raised?
Shennon Biotechnologies has raised $25.0M across 2 rounds on record. The most recent is an undisclosed round of $12.0M announced in Sep 2026.
When did Shennon Biotechnologies last raise funding?
Shennon Biotechnologies' most recent funding round on record is an undisclosed round of $12.0M, announced in Sep 2026.
Who has invested in Shennon Biotechnologies?
Investors on record for Shennon Biotechnologies include Future Ventures, DCVC, Foundation Capital, AV8 Ventures, NextGen Venture Partners. FundedIQ records 9 investors in total.
Who is the CEO of Shennon Biotechnologies?
Li Sun is listed as CEO at Shennon Biotechnologies.
Where is Shennon Biotechnologies headquartered?
Shennon Biotechnologies is based in San Francisco, California, United States.
How many employees does Shennon Biotechnologies have?
Shennon Biotechnologies is in the 11-50 employee band.
When was Shennon Biotechnologies founded?
Shennon Biotechnologies was founded in 2021.
How does Shennon Biotechnologies' funding compare to other Biotechnology startups?
Shennon Biotechnologies' latest round of $12.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Shennon Biotechnologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Shennon Biotechnologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.